MCL1 and colorectal carcinoma: In line with our aforementioned results (Williams et al., 2020), a colorectal cancer (CRC) focused study demonstrated that factors released by M2 polarised Mφs activate the ERK1/2-MCL-1 axis in immortalised and primary CRC cells (Lee et al., 2020).